DR info

Clinical trials : 5 / Drugs : 7 - (DrugBank : 5) / Drug target genes : 22 - Drug target pathways : 25

Fragile X syndrome related disease and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
205	Fragile X syndrome related disease
2	Amyotrophic lateral sclerosis
46	Malignant rheumatoid arthritis
13	Multiple sclerosis/Neuromyelitis optica
18	Spinocerebellar degeneration
3	Spinal muscular atrophy
70	Spinal stenosis
97	Ulcerative colitis
96	Crohn disease
6	Parkinson disease
21	Mitochondrial disease
206	Fragile X syndrome
17	Multiple system atrophy
5	Progressive supranuclear palsy
156	Rett syndrome
8	Huntington disease
75	Cushing disease
145	West syndrome
152	PCDH19 related syndrome
201	Angelman syndrome
84	Sarcoidosis
98	Eosinophilic gastrointestinal disease
272	Fibrodysplasia ossificans progressiva
296	Biliary atresia
22	Moyamoya disease
155	Acquired aphasia with convulsive disorder
193	Prader-Willi syndrome
298	Hereditary pancreatitis
231	Alpha-1-antitrypsin deficiency
158	Tuberous sclerosis
140	Dorabe syndrome
36	Epidermolysis bullosa
144	Lennox-Gastaut syndrome
34	Neurofibromatosis
78	Hypopituitarism
113	Muscular dystrophy
203	22q11.2 deletion syndrome
49	Systemic lupus erythematosus
127	Frontotemporal lobar degeneration
215	Tetralogy of Fallot
4	Primary lateral sclerosis
85	Idiopathic interstitial pneumonia
220	Rapidly progressive glomerulonephritis
30	Distal myopathy